2025.04.30
On February 27, 2025, Sichuan Anaerobic Biotechnology Co., Ltd. ("AnaeroBio") and Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Wedge Industrial Co., Ltd. (“Wedge”) with stock code 000534, signed a license agreement. The agreement grants exclusive rights for the industrialization and commercialization of AnaeroBio's innovate clinical-stage live biotherapeutic product (a vaginal quadrivalent Lactobacillus live capsule, project code: "KAL-001") in the Greater China region (including mainland China, Hong Kong, Macau and Taiwan). This was the first ever domestic transaction involving an innovative live biotherapeutic product.
JunHe was engaged by AnaeroBio to review and amend the agreement. The firm was trusted and recognized by the client for its consistently efficient and rigorous legal services and detail-oriented and professional expertise.
Partners ZHAO, Hao (Gerry), ZHAO, Jun and MA, Rui led the JunHe team.